Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

People undergoing chemotherapy need better support and information to cope with hair loss.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Treat pattern hair loss with finasteride and topical minoxidil.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Tamoxifen caused hair loss in a 52-year-old woman.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

PFS might be a delusional disorder with potential to become mass psychogenic illness.